Targeted therapy is required for management of pulmonary arterial hypertension after defect closure in adult patients with atrial septal defect and associated pulmonary arterial hypertension.

Abstract

BACKGROUND Therapeutic strategies for pulmonary arterial hypertension (PAH) associated with atrial septal defect (ASD) remain a matter of debate. METHODS AND RESULTS We identified 5 outpatients who had been diagnosed with ASD-PAH and undergone ASD closure in combination with targeted therapy with certified PAH drugs. We assessed changes in hemodynamic… (More)
DOI: 10.1536/ihj.14-183

Topics

Cite this paper

@article{Fujino2015TargetedTI, title={Targeted therapy is required for management of pulmonary arterial hypertension after defect closure in adult patients with atrial septal defect and associated pulmonary arterial hypertension.}, author={Takeo Fujino and Atsushi Yao and Masaru Hatano and Toshiro Inaba and Hironori Muraoka and Shun Minatsuki and Teruhiko Imamura and Hisataka Maki and Koichiro Kinugawa and Minoru Ono and Ryozo Nagai and Issei Komuro}, journal={International heart journal}, year={2015}, volume={56 1}, pages={86-93} }